Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

Ramus, S.J.
Kartsonaki, C.
Gayther, S.A.
Pharoah, P.D.
Sinilnikova, O.M.
Beesley, J.
Chen, X.
McGuffog, L.
Healey, S.
Couch, F.J.
Wang, X.
Fredericksen, Z.
Peterlongo, P.
Manoukian, S.
Peissel, B.
Zaffaroni, D.
Roversi, G.
Barile, M.
Viel, A.
Allavena, A.
Ottini, L.
Papi, L.
Gismondi, V.
Capra, F.
Radice, P.
Greene, M.H.
Mai, P.L.
Andrulis, I.L.
Glendon, G.
Ozcelik, H.
Thomassen, M.
Gerdes, A.M.
Kruse, T.A.
Cruger, D.
Jensen, U.B.
Caligo, M.A.
Olsson, H.
Kristoffersson, U.
Lindblom, A.
Arver, B.
Karlsson, P.
Stenmark Askmalm, M.
Borg, A.
Neuhausen, S.L.
Ding, Y.C.
Nathanson, K.L.
Domchek, S.M.
Jakubowska, A.
Lubinski, J.
Huzarski, T.
Byrski, T.
Gronwald, J.
Gorski, B.
Cybulski, C.
Debniak, T.
Osorio, A.
Duran, M.
Tejada, M.I.
Benitez, J.
Hamann, U.
Rookus, M.A.
Verhoef, S.
Tilanus-Linthorst, M.A.
Vreeswijk, M.P.
Bodmer, D.
Ausems, M.G.
Os, T.A. van
Asperen, C.J. van
Blok, M.J.
Meijers-Heijboer, H.E.
Peock, S.
Cook, M.
Oliver, C.
Frost, D.
Dunning, A.M.
Evans, D.G.
Eeles, R.
Pichert, G.
Cole, T.
Hodgson, S.
Brewer, C.
Morrison, P.J.
Porteous, M.
Kennedy, M.J.
Rogers, M.T.
Side, L.E.
Donaldson, A.
Gregory, H.
Godwin, A.
Stoppa-Lyonnet, D.
Moncoutier, V.
Castera, L.
Mazoyer, S.
Barjhoux, L.
Bonadona, V.
Leroux, D.
Faivre, L.
Lidereau, R.
Nogues, C.
Bignon, Y.J.
Prieur, F.
Collonge-Rame, M.A.
Venat-Bouvet, L.
Ligtenberg, M.J.L.
et al.

January 2011

Item does not contain fulltextBACKGROUND: Germline mutations in the BRCA1 and BRCA2 genes are associ...

Hormonal modifiers of breast and ovarian cancer risk in BRCA1/2 mutation carriers

Schrijver, Lieske Heleen

September 2022

Women who carry a pathogenic variant (mutation) in the BRCA1 or BRCA2 genes have a high lifetime ris...

and the Hereditary Ovarian Cancer Clinical Study Group Summary

January 2007

Background Several of the known risk factors for ovarian cancer are thought to act through their eff...

Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers

January 2018

Background: The effect of in vitro fertilisation (IVF) on breast cancer risk for BRCA1/2 mutation ca...

Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers

Derks-Smeets, Inge A. P.
Schrijver, Lieske H.
de Die-Smulders, Christine E. M.
Tjan-Heijnen, Vivianne C. G.
van Golde, Ron J. T.
Smits, Luc J.
Caanen, Beppy
van Asperen, Christi J.
Ausems, Margreet
Collee, Margriet
van Engelen, Klaartje
Kets, C. Marleen
van der Kolk, Lizet
Oosterwijk, Jan C.
van Os, Theo A. M.
Rookus, Matti A.
van Leeuwen, Flora E.
Garcia, Encarna B.

August 2018

BACKGROUND: The effect of in vitro fertilisation (IVF) on breast cancer risk for BRCA1/2 mutation ca...

Multidimensional perspective on ovarian cancer risk reduction in BRCA1/2 mutation carriers

Arts-de Jong, M.

January 2018

Contains fulltext : 183429.pdf (publisher's version ) (Open Access)21 maart 2018Pr...

Reproductive and Hormonal Factors, and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Results from the International BRCA1/2 Carrier Cohort Study

Antoniou, Antonis C.
Rookus, Matti
Andrieu, Nadine
Brohet, Richard
Chang-Claude, Jenny
Peock, Susan
Cook, Margaret
Evans, D. Gareth
Eeles, Rosalind
Nogues, Catherine
Faivre, Laurence
Gesta, Paul
van Leeuwen, Flora E.
Ausems, Margreet G. E. M.
Sorio, Ana
Caldes, Trinidad
Simard, Jacques
Lubinski, Jan
Gerdes, Anne-Marie
Olah, Edith
Fuerhauser, Christine
Olsson, Håkan
Arver, Brita
Radice, Paolo
Easton, Douglas F.
Goldgarl, David E.

January 2009

Background: Several reproductive and hormonal factors are known to be associated with ovarian cancer...

Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas.

Weren, R.D.A.
Mensenkamp, A.R.
Simons, M.
Eijkelenboom, A.
Sie, A.S.
Ouchene, H.
Asseldonk, M. van
Gomez-Garcia, E.B.
Blok, M.J.
Hullu, J.A. de
Nelen, M.R.
Hoischen, A.
Bulten, J.
Tops, B.B.J.
Hoogerbrugge, N.
Ligtenberg, M.J.L.

January 2017

Contains fulltext : 170272.pdf (publisher's version ) (Open Access

Early detection of breast and ovarian cancer in families with BRCA mutations.

Vasen, H.F.
Tesfay, E.
Boonstra, H.
Mourits, M.J.E.
Rutgers, E.
Verheyen, R.
Oosterwijk-Wakka, J.C.
Beex, L.V.A.M.

January 2005

Contains fulltext : 48740.pdf (publisher's version ) (Closed access)Women at risk ...

Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

Kotsopoulos, J.
Lubinski, J.
Neuhausen, S. L.
Lynch, H. T.
Rosen, B.
Ainsworth, P.
Moller, P.
Ghadirian, P.
Isaacs, C.
Karlan, B.
Sun, P.
Narod, S. A.

January 2006

This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...

Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the international BRCA1/2 carrier cohort study

Antoniou, A.C.
Rookus, M.
Andrieu, N.
Brohet, R.
Chang-Claude, J.
Peock, S.
Cook, M.
Evans, D.G.
Eeles, R.
Nogues, C.
Faivre, L.
Gesta, P.
van Leeuwen, F.E.
Ausems, M.G.E.M.
Osorio, A.
Caldes, T.
Simard, J.
Lubinski, J.
Gerdes, A.-M.
Olah, E.
Furhauser, C.
Olsson, H.
Arver, B.
Radice, P.
Easton, D.F.
Goldgar, D.E.
Tobias, E.S.

February 2009

Background: Several reproductive and hormonal factors are known to be associated with ovari...

Salpingectomy with delayed oophorectomy in BRCA1/2 mutation carriers

Harmsen, M.G.

January 2017

Contains fulltext : 173261.pdf (publisher's version ) (Open Access)Radboud Univers...

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

Peterlongo, P.
Chang-Claude, J.
Moysich, K.B.
Rudolph, A.
Schmutzler, R.K.
Simard, J.
Soucy, P.
Eeles, R.A.
Easton, D.F.
Hamann, U.
Wilkening, S.
Chen, B.
Rookus, M.A.
Schmidt, M.K.
Baan, F.H. van der
Spurdle, A.B.
Walker, L.C.
Lose, F.
Maia, A.T.
Montagna, M.
Matricardi, L.
Lubinski, J.
Jakubowska, A.
Garcia, E.B.
Olopade, O.I.
Nussbaum, R.L.
Nathanson, K.L.
Domchek, S.M.
Rebbeck, T.R.
Arun, B.K.
Karlan, B.Y.
Orsulic, S.
Lester, J.
Chung, W.K.
Miron, A.
Southey, M.C.
Goldgar, D.E.
Buys, S.S.
Janavicius, R.
Dorfling, C.M.
Rensburg, E.J. van
Ding, Y.C.
Neuhausen, S.L.
Hansen, T.V.
Gerdes, A.M.
Ejlertsen, B.
Jonson, L.
Osorio, A.
Martinez-Bouzas, C.
Benitez, J.
Conway, E.E.
Blazer, K.R.
Weitzel, J.N.
Manoukian, S.
Peissel, B.
Zaffaroni, D.
Scuvera, G.
Barile, M.
Ficarazzi, F.
Mariette, F.
Fortuzzi, S.
Viel, A.
Giannini, G.
Papi, L.
Martayan, A.
Tibiletti, M.G.
Radice, P.
Vratimos, A.
Fostira, F.
Garber, J.E.
Donaldson, A.
Brewer, C.
Foo, C.
Evans, D.G.
Frost, D.
Eccles, D.
Brady, A.
Cook, J.
Tischkowitz, M.
Adlard, J.
Barwell, J.
Izatt, L.
Side, L.E.
Kennedy, M.J.
Rogers, M.T.
Porteous, M.E.
Morrison, P.J.
Platte, R.
Davidson, R.
Hodgson, S.V.
Ellis, S.
Cole, T.
Godwin, A.K.
Claes, K.
Maerken, T. Van
Meindl, A.
Gehrig, A.
Sutter, C.
Engel, C.
Hoogerbrugge, N.
et al.

January 2015

Contains fulltext : 154702.pdf (publisher's version ) (Closed access)BACKGROUND: B...

Prospects in the management of ovarian cancer: with special reference to Human Tumour Cloning

Verheijen, R.H.M.

January 1985

Contains fulltext : mmubn000001_028916395.pdf (publisher's version ) (Open Access)...

Ovarian Stimulation for In Vitro Fertilization and Long-term Risk of Breast Cancer

Belt-Dusebout, A.W. van den
Spaan, M.
Lambalk, C.B.
Kortman, M.
Laven, J.S.
Santbrink, E.J. van
Westerlaken, L.A. van der
Cohlen, B.J.
Braat, D.D.M.
Smeenk, J.M.
Land, J.A.
Goddijn, M.
Golde, R.J. van
Rumste, M.M. van
Schats, R.
Jozwiak, K.
Hauptmann, M.
Rookus, M.A.
Burger, C.W.
Leeuwen, F.E. van

January 2016

Item does not contain fulltextIMPORTANCE: Previous studies of breast cancer risk after in vitro fert...

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

Ramus, S.J.
Kartsonaki, C.
Gayther, S.A.
Pharoah, P.D.
Sinilnikova, O.M.
Beesley, J.
Chen, X.
McGuffog, L.
Healey, S.
Couch, F.J.
Wang, X.
Fredericksen, Z.
Peterlongo, P.
Manoukian, S.
Peissel, B.
Zaffaroni, D.
Roversi, G.
Barile, M.
Viel, A.
Allavena, A.
Ottini, L.
Papi, L.
Gismondi, V.
Capra, F.
Radice, P.
Greene, M.H.
Mai, P.L.
Andrulis, I.L.
Glendon, G.
Ozcelik, H.
Thomassen, M.
Gerdes, A.M.
Kruse, T.A.
Cruger, D.
Jensen, U.B.
Caligo, M.A.
Olsson, H.
Kristoffersson, U.
Lindblom, A.
Arver, B.
Karlsson, P.
Stenmark Askmalm, M.
Borg, A.
Neuhausen, S.L.
Ding, Y.C.
Nathanson, K.L.
Domchek, S.M.
Jakubowska, A.
Lubinski, J.
Huzarski, T.
Byrski, T.
Gronwald, J.
Gorski, B.
Cybulski, C.
Debniak, T.
Osorio, A.
Duran, M.
Tejada, M.I.
Benitez, J.
Hamann, U.
Rookus, M.A.
Verhoef, S.
Tilanus-Linthorst, M.A.
Vreeswijk, M.P.
Bodmer, D.
Ausems, M.G.
Os, T.A. van
Asperen, C.J. van
Blok, M.J.
Meijers-Heijboer, H.E.
Peock, S.
Cook, M.
Oliver, C.
Frost, D.
Dunning, A.M.
Evans, D.G.
Eeles, R.
Pichert, G.
Cole, T.
Hodgson, S.
Brewer, C.
Morrison, P.J.
Porteous, M.
Kennedy, M.J.
Rogers, M.T.
Side, L.E.
Donaldson, A.
Gregory, H.
Godwin, A.
Stoppa-Lyonnet, D.
Moncoutier, V.
Castera, L.
Mazoyer, S.
Barjhoux, L.
Bonadona, V.
Leroux, D.
Faivre, L.
Lidereau, R.
Nogues, C.
Bignon, Y.J.
Prieur, F.
Collonge-Rame, M.A.
Venat-Bouvet, L.
Ligtenberg, M.J.L.
et al.

January 2011

Item does not contain fulltextBACKGROUND: Germline mutations in the BRCA1 and BRCA2 genes are associ...

Hormonal modifiers of breast and ovarian cancer risk in BRCA1/2 mutation carriers

Schrijver, Lieske Heleen

September 2022

Women who carry a pathogenic variant (mutation) in the BRCA1 or BRCA2 genes have a high lifetime ris...

and the Hereditary Ovarian Cancer Clinical Study Group Summary

January 2007

Background Several of the known risk factors for ovarian cancer are thought to act through their eff...

Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers

January 2018

Background: The effect of in vitro fertilisation (IVF) on breast cancer risk for BRCA1/2 mutation ca...

Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers

Derks-Smeets, Inge A. P.
Schrijver, Lieske H.
de Die-Smulders, Christine E. M.
Tjan-Heijnen, Vivianne C. G.
van Golde, Ron J. T.
Smits, Luc J.
Caanen, Beppy
van Asperen, Christi J.
Ausems, Margreet
Collee, Margriet
van Engelen, Klaartje
Kets, C. Marleen
van der Kolk, Lizet
Oosterwijk, Jan C.
van Os, Theo A. M.
Rookus, Matti A.
van Leeuwen, Flora E.
Garcia, Encarna B.

August 2018

BACKGROUND: The effect of in vitro fertilisation (IVF) on breast cancer risk for BRCA1/2 mutation ca...

Multidimensional perspective on ovarian cancer risk reduction in BRCA1/2 mutation carriers

Arts-de Jong, M.

January 2018

Contains fulltext : 183429.pdf (publisher's version ) (Open Access)21 maart 2018Pr...

Reproductive and Hormonal Factors, and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Results from the International BRCA1/2 Carrier Cohort Study

Antoniou, Antonis C.
Rookus, Matti
Andrieu, Nadine
Brohet, Richard
Chang-Claude, Jenny
Peock, Susan
Cook, Margaret
Evans, D. Gareth
Eeles, Rosalind
Nogues, Catherine
Faivre, Laurence
Gesta, Paul
van Leeuwen, Flora E.
Ausems, Margreet G. E. M.
Sorio, Ana
Caldes, Trinidad
Simard, Jacques
Lubinski, Jan
Gerdes, Anne-Marie
Olah, Edith
Fuerhauser, Christine
Olsson, Håkan
Arver, Brita
Radice, Paolo
Easton, Douglas F.
Goldgarl, David E.

January 2009

Background: Several reproductive and hormonal factors are known to be associated with ovarian cancer...

Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas.

Weren, R.D.A.
Mensenkamp, A.R.
Simons, M.
Eijkelenboom, A.
Sie, A.S.
Ouchene, H.
Asseldonk, M. van
Gomez-Garcia, E.B.
Blok, M.J.
Hullu, J.A. de
Nelen, M.R.
Hoischen, A.
Bulten, J.
Tops, B.B.J.
Hoogerbrugge, N.
Ligtenberg, M.J.L.

January 2017

Contains fulltext : 170272.pdf (publisher's version ) (Open Access

Early detection of breast and ovarian cancer in families with BRCA mutations.

Vasen, H.F.
Tesfay, E.
Boonstra, H.
Mourits, M.J.E.
Rutgers, E.
Verheyen, R.
Oosterwijk-Wakka, J.C.
Beex, L.V.A.M.

January 2005

Contains fulltext : 48740.pdf (publisher's version ) (Closed access)Women at risk ...

Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

Kotsopoulos, J.
Lubinski, J.
Neuhausen, S. L.
Lynch, H. T.
Rosen, B.
Ainsworth, P.
Moller, P.
Ghadirian, P.
Isaacs, C.
Karlan, B.
Sun, P.
Narod, S. A.

January 2006

This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...

Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the international BRCA1/2 carrier cohort study

Antoniou, A.C.
Rookus, M.
Andrieu, N.
Brohet, R.
Chang-Claude, J.
Peock, S.
Cook, M.
Evans, D.G.
Eeles, R.
Nogues, C.
Faivre, L.
Gesta, P.
van Leeuwen, F.E.
Ausems, M.G.E.M.
Osorio, A.
Caldes, T.
Simard, J.
Lubinski, J.
Gerdes, A.-M.
Olah, E.
Furhauser, C.
Olsson, H.
Arver, B.
Radice, P.
Easton, D.F.
Goldgar, D.E.
Tobias, E.S.

February 2009

Background: Several reproductive and hormonal factors are known to be associated with ovari...

Salpingectomy with delayed oophorectomy in BRCA1/2 mutation carriers

Harmsen, M.G.

January 2017

Contains fulltext : 173261.pdf (publisher's version ) (Open Access)Radboud Univers...

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

Peterlongo, P.
Chang-Claude, J.
Moysich, K.B.
Rudolph, A.
Schmutzler, R.K.
Simard, J.
Soucy, P.
Eeles, R.A.
Easton, D.F.
Hamann, U.
Wilkening, S.
Chen, B.
Rookus, M.A.
Schmidt, M.K.
Baan, F.H. van der
Spurdle, A.B.
Walker, L.C.
Lose, F.
Maia, A.T.
Montagna, M.
Matricardi, L.
Lubinski, J.
Jakubowska, A.
Garcia, E.B.
Olopade, O.I.
Nussbaum, R.L.
Nathanson, K.L.
Domchek, S.M.
Rebbeck, T.R.
Arun, B.K.
Karlan, B.Y.
Orsulic, S.
Lester, J.
Chung, W.K.
Miron, A.
Southey, M.C.
Goldgar, D.E.
Buys, S.S.
Janavicius, R.
Dorfling, C.M.
Rensburg, E.J. van
Ding, Y.C.
Neuhausen, S.L.
Hansen, T.V.
Gerdes, A.M.
Ejlertsen, B.
Jonson, L.
Osorio, A.
Martinez-Bouzas, C.
Benitez, J.
Conway, E.E.
Blazer, K.R.
Weitzel, J.N.
Manoukian, S.
Peissel, B.
Zaffaroni, D.
Scuvera, G.
Barile, M.
Ficarazzi, F.
Mariette, F.
Fortuzzi, S.
Viel, A.
Giannini, G.
Papi, L.
Martayan, A.
Tibiletti, M.G.
Radice, P.
Vratimos, A.
Fostira, F.
Garber, J.E.
Donaldson, A.
Brewer, C.
Foo, C.
Evans, D.G.
Frost, D.
Eccles, D.
Brady, A.
Cook, J.
Tischkowitz, M.
Adlard, J.
Barwell, J.
Izatt, L.
Side, L.E.
Kennedy, M.J.
Rogers, M.T.
Porteous, M.E.
Morrison, P.J.
Platte, R.
Davidson, R.
Hodgson, S.V.
Ellis, S.
Cole, T.
Godwin, A.K.
Claes, K.
Maerken, T. Van
Meindl, A.
Gehrig, A.
Sutter, C.
Engel, C.
Hoogerbrugge, N.
et al.

January 2015

Contains fulltext : 154702.pdf (publisher's version ) (Closed access)BACKGROUND: B...

Prospects in the management of ovarian cancer: with special reference to Human Tumour Cloning

Verheijen, R.H.M.

January 1985

Contains fulltext : mmubn000001_028916395.pdf (publisher's version ) (Open Access)...

Ovarian Stimulation for In Vitro Fertilization and Long-term Risk of Breast Cancer

Belt-Dusebout, A.W. van den
Spaan, M.
Lambalk, C.B.
Kortman, M.
Laven, J.S.
Santbrink, E.J. van
Westerlaken, L.A. van der
Cohlen, B.J.
Braat, D.D.M.
Smeenk, J.M.
Land, J.A.
Goddijn, M.
Golde, R.J. van
Rumste, M.M. van
Schats, R.
Jozwiak, K.
Hauptmann, M.
Rookus, M.A.
Burger, C.W.
Leeuwen, F.E. van

January 2016

Item does not contain fulltextIMPORTANCE: Previous studies of breast cancer risk after in vitro fert...

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

Ramus, S.J.
Kartsonaki, C.
Gayther, S.A.
Pharoah, P.D.
Sinilnikova, O.M.
Beesley, J.
Chen, X.
McGuffog, L.
Healey, S.
Couch, F.J.
Wang, X.
Fredericksen, Z.
Peterlongo, P.
Manoukian, S.
Peissel, B.
Zaffaroni, D.
Roversi, G.
Barile, M.
Viel, A.
Allavena, A.
Ottini, L.
Papi, L.
Gismondi, V.
Capra, F.
Radice, P.
Greene, M.H.
Mai, P.L.
Andrulis, I.L.
Glendon, G.
Ozcelik, H.
Thomassen, M.
Gerdes, A.M.
Kruse, T.A.
Cruger, D.
Jensen, U.B.
Caligo, M.A.
Olsson, H.
Kristoffersson, U.
Lindblom, A.
Arver, B.
Karlsson, P.
Stenmark Askmalm, M.
Borg, A.
Neuhausen, S.L.
Ding, Y.C.
Nathanson, K.L.
Domchek, S.M.
Jakubowska, A.
Lubinski, J.
Huzarski, T.
Byrski, T.
Gronwald, J.
Gorski, B.
Cybulski, C.
Debniak, T.
Osorio, A.
Duran, M.
Tejada, M.I.
Benitez, J.
Hamann, U.
Rookus, M.A.
Verhoef, S.
Tilanus-Linthorst, M.A.
Vreeswijk, M.P.
Bodmer, D.
Ausems, M.G.
Os, T.A. van
Asperen, C.J. van
Blok, M.J.
Meijers-Heijboer, H.E.
Peock, S.
Cook, M.
Oliver, C.
Frost, D.
Dunning, A.M.
Evans, D.G.
Eeles, R.
Pichert, G.
Cole, T.
Hodgson, S.
Brewer, C.
Morrison, P.J.
Porteous, M.
Kennedy, M.J.
Rogers, M.T.
Side, L.E.
Donaldson, A.
Gregory, H.
Godwin, A.
Stoppa-Lyonnet, D.
Moncoutier, V.
Castera, L.
Mazoyer, S.
Barjhoux, L.
Bonadona, V.
Leroux, D.
Faivre, L.
Lidereau, R.
Nogues, C.
Bignon, Y.J.
Prieur, F.
Collonge-Rame, M.A.
Venat-Bouvet, L.
Ligtenberg, M.J.L.
et al.

January 2011

Item does not contain fulltextBACKGROUND: Germline mutations in the BRCA1 and BRCA2 genes are associ...

Hormonal modifiers of breast and ovarian cancer risk in BRCA1/2 mutation carriers

Schrijver, Lieske Heleen

September 2022

Women who carry a pathogenic variant (mutation) in the BRCA1 or BRCA2 genes have a high lifetime ris...

and the Hereditary Ovarian Cancer Clinical Study Group Summary

January 2007

Background Several of the known risk factors for ovarian cancer are thought to act through their eff...

Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers

Abstract

Extracted data

Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers

Abstract

Extracted data

Related items

Related items